awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34913785-08C53F73-4CE0-45B6-A49F-E6FC15CD3AC3
Q34913785-08C53F73-4CE0-45B6-A49F-E6FC15CD3AC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34913785-08C53F73-4CE0-45B6-A49F-E6FC15CD3AC3
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.
P2860
Q34913785-08C53F73-4CE0-45B6-A49F-E6FC15CD3AC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34913785-08C53F73-4CE0-45B6-A49F-E6FC15CD3AC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e660397d9336b40ebf9be6cfc6c3235ba9e66244
P2860
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.